Patients were then divided into PRR34‐AS1 hypermethylated group and hypomethylated group based on ROC analysis in order to explore the relationship between PRR34‐AS1 methylation and different clinical parameters in AML. This evidence concerns the gene PRR34 and acute myeloid leukemia.